PSS29 Real-World Characteristics and Severity Assessment of United States Health Plan Members Treated with Ustekinumab for Moderate-to-Severe Psoriasis
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1373
https://www.valueinhealthjournal.com/article/S1098-3015(12)01438-6/fulltext
Title :
PSS29 Real-World Characteristics and Severity Assessment of United States Health Plan Members Treated with Ustekinumab for Moderate-to-Severe Psoriasis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01438-6&doi=10.1016/j.jval.2012.03.1373
First page :
A255
Section Title :
Sensory Systems Disorders
Open access? :
No
Section Order :
909